The U.S. Food and Drug Administration (FDA) will host a webinar in early February on its requirements regarding the electromagnetic compatibility (EMC) of in vitro diagnostic (IVD) medical devices.
According to a posting on the FDA’s website, the one-hour webinar on February 2nd will discuss the agency’s final guidance on “Electromagnetic Compatibility (EMC) of Medical Devices,” issued in June 2022, which provides the FDA’s recommendations on testing to assess the EMC of medical devices, as well as testing information to be included in an IVD premarket submission.
Registration for the FDA’s webinar on EMC and IVD devices is not required. Readers can find instructions for logging into the session here.